Literature DB >> 18304678

Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.

Paolo Angeli1, Carlo Merkel.   

Abstract

Hepatorenal syndrome is a severe complication of advanced liver cirrhosis, in patients with ascites and marked circulatory dysfunction. It is clearly established that it has a functional nature, and that it is related to intense renal vasoconstriction. Despite its functional origin, the prognosis is very poor. In the present review, the most recent advances in diagnosis, pathophysiology, and treatment are discussed. Recent developments in pathophysiology are the basis of the new therapeutic strategies, which are currently under evaluation in randomised clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18304678     DOI: 10.1016/j.jhep.2008.01.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

Review 1.  Acute kidney injury in acute on chronic liver failure.

Authors:  Rakhi Maiwall; S K Sarin; Richard Moreau
Journal:  Hepatol Int       Date:  2015-10-15       Impact factor: 6.047

2.  Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis.

Authors:  Hong Zang; Fangfang Liu; Hongling Liu; Shaoli You; Bing Zhu; Zhihong Wan; Shaojie Xin
Journal:  Hepatol Int       Date:  2016-08-02       Impact factor: 6.047

Review 3.  Sepsis-induced acute kidney injury in patients with cirrhosis.

Authors:  Paolo Angeli; Marta Tonon; Chiara Pilutti; Filippo Morando; Salvatore Piano
Journal:  Hepatol Int       Date:  2015-07-04       Impact factor: 6.047

4.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

5.  Diabetes increases renovascular impedance in patients with liver cirrhosis.

Authors:  Luisa Spadaro; Graziella Privitera; Giuseppe Fede; Orazio Magliocco; Maurizio Russello; Salvatore Piro; Agata Maria Rabuazzo; Francesco Purrello
Journal:  Intern Emerg Med       Date:  2015-04-12       Impact factor: 3.397

6.  Management of refractory ascites and hepatorenal syndrome.

Authors:  Amy N Sussman; Thomas D Boyer
Journal:  Curr Gastroenterol Rep       Date:  2011-02

7.  Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2.

Authors:  Marc Nguyen-Tat; Julia Jäger; Johannes Wilhelm Rey; Michael Nagel; Christian Labenz; Marcus-Alexander Wörns; Peter Robert Galle; Jens Uwe Marquardt
Journal:  United European Gastroenterol J       Date:  2019-02-20       Impact factor: 4.623

8.  Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome.

Authors:  Abhasnee Sobhonslidsuk
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 9.  Modulation of splanchnic circulation: Role in perioperative management of liver transplant patients.

Authors:  Ahmed Mukhtar; Hany Dabbous
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 10.  Systemic abnormalities in liver disease.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.